FiercePharma | Nachrichten

Zeit	Aktuelle Nachrichten
Fr	FDA slaps new bladder cancer limits on Merck's Keytruda, Roche's Tecentriq
Fr	FDA accepts Bristol-Myers' Opdivo-Yervoy app in lung cancer, but without a speedy review
Fr	NICE reconsiders and agrees to back Roche's Ocrevus in relapsing multiple sclerosis-with strings attached
Fr	Shire wins FDA approval to make Gammagard Liquid at new U.S. plant, ramps up hiring
Fr	Sanofi's Dupixent scores NICE recommendation after price cut
Fr	FiercePharmaAsia-China's first I-O nod, Dr. Reddy's Suboxone generic, MNC-to-biotech shifts
Do	FDA pressured to revoke Takeda's popular gout drug Uloric due to death concerns
Do	Novo Nordisk's oral semaglutide impresses analysts against Victoza, Januvia
Do	GlaxoSmithKline limits Shingrix orders, halts TV commercials amid 'unprecedented' demand
Do	Novartis pads Cosentyx's psoriatic arthritis lead with joint-damage label update
Do	Shire scores new FDA thumbs-up for HAE drug Cinryze in latest bid to fend off rival CSL
Do	After making $1M+ on illegal trades, former Puma Biotechnology executive gets prison term
Do	French regulators cite contamination, other issues at factory of Indian API maker Dhanuka Labs
Mi	Frances's Novacap scoops up U.S. CDMO
Mi	CDMO Minakem's new Belgium HPAPI facility in final qualifications ahead of opening
Mi	CVC weighs $3B-plus Recordati buy, but family and political drama could scuttle talks: FT
Mi	Drug shortages again on the rise after 5 years of improvements, FDA says
Mi	Opioid maker Purdue deep-sixes sales team amid mass layoff and mounting legal woes
Mi	Why is AbbVie's tax rate so low? Humira patents cached in Bermuda: Reuters
Mi	AbbVie put gaming gremlins to work mining people's 'fear of finding out' they're sick
Mi	Lions Health: Mylan CEO talks big and small creative ideas that make a difference
Mi	Pfizer's 'Living With Cancer' wowed Cannes attendees, if not the pharma jury
Mi	News of Note-Vaccine exemption 'hot spots,' NIAID's RSV vaccine study and more
Mi	Doctors worry Shingrix side effects will put patients off their second dose
Mi	Lions Health, Day 2: Fear factors, pharma humor and how can we win next year?

Zeit

Aktuelle Nachrichten

FDA slaps new bladder cancer limits on Merck's Keytruda, Roche's Tecentriq

FDA accepts Bristol-Myers' Opdivo-Yervoy app in lung cancer, but without a speedy review

NICE reconsiders and agrees to back Roche's Ocrevus in relapsing multiple sclerosis-with strings attached

Shire wins FDA approval to make Gammagard Liquid at new U.S. plant, ramps up hiring

Sanofi's Dupixent scores NICE recommendation after price cut

FiercePharmaAsia-China's first I-O nod, Dr. Reddy's Suboxone generic, MNC-to-biotech shifts

FDA pressured to revoke Takeda's popular gout drug Uloric due to death concerns

Novo Nordisk's oral semaglutide impresses analysts against Victoza, Januvia

GlaxoSmithKline limits Shingrix orders, halts TV commercials amid 'unprecedented' demand

Novartis pads Cosentyx's psoriatic arthritis lead with joint-damage label update

Shire scores new FDA thumbs-up for HAE drug Cinryze in latest bid to fend off rival CSL

After making $1M+ on illegal trades, former Puma Biotechnology executive gets prison term

French regulators cite contamination, other issues at factory of Indian API maker Dhanuka Labs

Frances's Novacap scoops up U.S. CDMO

CDMO Minakem's new Belgium HPAPI facility in final qualifications ahead of opening

CVC weighs $3B-plus Recordati buy, but family and political drama could scuttle talks: FT

Drug shortages again on the rise after 5 years of improvements, FDA says

Opioid maker Purdue deep-sixes sales team amid mass layoff and mounting legal woes

Why is AbbVie's tax rate so low? Humira patents cached in Bermuda: Reuters

AbbVie put gaming gremlins to work mining people's 'fear of finding out' they're sick

Lions Health: Mylan CEO talks big and small creative ideas that make a difference

Pfizer's 'Living With Cancer' wowed Cannes attendees, if not the pharma jury

News of Note-Vaccine exemption 'hot spots,' NIAID's RSV vaccine study and more

Doctors worry Shingrix side effects will put patients off their second dose

Lions Health, Day 2: Fear factors, pharma humor and how can we win next year?

Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von

Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Xetra-Orderbuch

Devisen	Kurs	%

Rohstoffe	Kurs	%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)

Aktuelle News von FiercePharma